Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.035 USD | -0.69% | +2.24% | -25.70% |
May. 08 | Mizuho Adjusts uniQure's Price Target to $6 From $7, Keeps Neutral Rating | MT |
May. 07 | UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.70% | 246M | |
+8.65% | 114B | |
+11.33% | 104B | |
-12.73% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.07% | 17.89B | |
+7.97% | 14.28B | |
+35.31% | 12.55B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure's Partner CSL Gets European Commission Approval for Hemgenix to Treat Hemophilia B